Yuuki Technologies Information

Most healthcare AI doesn't fail. It just never arrives. The demo works, the board is enthusiastic, the vendor is credible, and eighteen months later it's still a pilot running alongside the process it was meant to replace. I work on that gap: why it opens, how to tell before you spend whether an organization can close it, and what has to be true for AI to survive production. I came at it from three directions that rarely sit in one person. Clinically, as a physician who knows what actually changes at the bedside. Technically, through product leadership across large pharma, a national health system, and health tech. Commercially, from the buying side: I've owned vendor selection and build-versus-buy calls, and built and exited two healthcare technology companies. The value isn't depth in any one; it's translating between them in front of a buyer, without a deck. Yuuki Advisory serves mid-market healthcare: community and regional systems, specialty groups, home health and post-acute, regional payers, all with a real AI mandate and no path to an enterprise platform deal. Deployment Readiness Index: your organization scored across ten dimensions before you build or buy. Two weeks. Reliability Gate: a defensible pass/fail on production readiness, scored against a taxonomy of silent failures, the ones that never throw an error, they just stop being right. Deployment engagements: six to twelve weeks, fixed scope and fee. Yuuki Sentinel: zero-PHI monitoring, so degradation surfaces before patients or auditors do. A health-tech AI content engine with clinical oversight. Care Bridge cut referral intake from 45 minutes to under 3. CardioWatch is a cardiac remote-monitoring build. I write Yuuki Edge weekly and Yuuki Institutional, a paid brief with named calls, published falsifiers, and a 90-day review clock. No vendor pays for coverage. If you have a pilot that hasn't moved in two quarters, that's the conversation I want. support@yuukiadvisory.com